Department of Endocrinology and Diabetes, Princess Margaret Hospital for Children, Perth, WA, Australia
Expert Review
Suspension vs Conventional Pump Therapy for Hypoglycemic Unaware Patients with Type 1 Diabetes
Author(s): Tim Jones*
In patients with type 1 diabetes who lack awareness of hypoglycaemia,
the objective was to compare the cost-effectiveness of sensor-augmented
insulin pump therapy with "Low Glucose Suspend" (LGS) functionality to
standard pump therapy with self-monitoring of blood glucose.
Methods: The net costs and effectiveness of the two treatment options
were calculated and expressed as an incremental cost-effectiveness ratio
(ICER) in an economic evaluation based on a clinical trial. The rate of severe
hypoglycaemia in each LGS study arm was the clinical outcome of interest
for the evaluation. Personal satisfaction utility scores were determined
utilizing the three-level EuroQol five-layered survey. Costs associated with
resource use were estimated using public data.
Results: At six months, compared to standar.. View More»
DOI:
10.35248/2155-6156.1000980
